IR Contacts
If you would like further information or have questions or comments, please contact:
John Lacey, MS, MBA
Head of Corporate Communications & Investor Relations
+1-781-392-5514
IR@BioLineRx.com
John Lacey, MS, MBA
Head of Corporate Communications & Investor Relations
+1-781-392-5514
IR@BioLineRx.com
BioLineRx Reports 2022 Financial Results and Recent Corporate and Portfolio Updates
BioLineRx to Report 2022 Annual Financial Results on March 22, 2023